|
|
||||||||
Ann Thorac Surg 2006;81:1839-1843
© 2006 The Society of Thoracic Surgeons
a Pulmonary Medicine, University Hospital Basel, Switzerland
b Department of Pulmonology, Thoraxklinik, University Heidelberg, Germany
c Department of Thoracic Surgery, Thoraxklinik, University Heidelberg, Germany
Accepted for publication November 28, 2005.
* Address correspondence to Dr Chhajed, Pulmonary Medicine, University Hospital Basel, Petersgraben 4, Basel CH-4031, Switzerland (Email: pchhajed{at}uhbs.ch).
| Abstract |
|---|
|
|
|---|
METHODS: Seventy-four consecutive patients with nonsmall cell lung carcinoma undergoing a therapeutic bronchoscopy procedure followed by surgery with a curative intent were included.
RESULTS: A single interventional bronchoscopic method was used in 27 patients (36%) and a combination of methods in 47 patients (64%). Median forced expiratory volume in 1 second (FEV1) before and after bronchoscopy were 1.7 L and 2.2 L, respectively, and forced vital capacity (FVC) was 2.5 L and 3.3 L, respectively. Sleeve upper lobectomy was performed in 22 patients (30%), sleeve upper bilobectomy in 16 patients (22%), lower bilobectomy in 2 patients (3%), pneumonectomy with sleeve resection in 2 patients (3%), and pneumonectomy in 28 patients (38%). The following surgeries were performed in 1 patient each: sleeve middle lobectomy, sleeve lower lobectomy, carina resection and complex reconstruction, and exploratory thoracotomy. Overall, parenchyma-sparing surgery (lobectomy or bilobectomy) could be performed in 57% patients after therapeutic bronchoscopy. There were no in-hospital deaths or deaths in the first 30 days after surgery.
CONCLUSIONS: Therapeutic bronchoscopy can be used as a complementary tool in the combined bronchoscopic and surgical management of malignant airway obstruction before curative lung surgery. Therapeutic bronchoscopy might permit parenchyma-sparing surgery in patients with lung cancer.
| Introduction |
|---|
|
|
|---|
A recent meta-analysis of results of sleeve lobectomy and pneumonectomy has concluded that sleeve lobectomy offers better long-term survival and quality of life than does pneumonectomy and is more cost effective [8]. Recanalization of central airway obstruction using therapeutic bronchoscopic modalities allows the assessment of the extent of malignant airway involvement and the status of the airway distal to the obstruction, and thus better endobronchial staging of lung cancer. Bronchoscopic intervention before pulmonary resection also leads to improvement in lung function [6, 7]. There are limited data about using a combined bronchoscopic and surgical approach to increase the possibility of offering the patient parenchyma-sparing surgery [6, 7, 9, 10]. The aim of this study was to assess the utility of therapeutic bronchoscopy modalities as complementary tools in the combined bronchoscopic and surgical management of malignant airway lesions before curative lung surgery.
| Patients and Methods |
|---|
|
|
|---|
Rigid bronchoscopy under general anesthesia was performed in all patients [3]. If necessary, the flexible bronchoscope was inserted through the rigid bronchoscope. Laser, argon plasma coagulation or contact electrocautery probes were used based on operator preference. These probes were passed either through the rigid bronchoscope or the working channel of the flexible bronchoscope. Mechanical coring of the tumor was performed with the rotating movement of the tip of the rigid bronchoscope [3]. Stent insertion was undertaken in selected patients with lung cancer in whom it was not possible to achieve more than 50% opening of the airway diameter and were removed at surgical resection. Surgical resection was performed 1 to 23 weeks after the therapeutic bronchoscopy procedure. Before and after therapeutic bronchoscopy spirometry data were available in 73 patients (99%). Postprocedure spirometry was performed within 1 week after the therapeutic bronchoscopy.
Statistical Methods
Data are presented as median and range. The Mann-Whitney test was used to compare the differences between two means.
| Results |
|---|
|
|
|---|
A single interventional bronchoscopic method was used in 27 patients (38%), and in the remaining 47 patients (62%), a combination of methods was used to relieve endobronchial obstruction. A single modality was used as follows: laser resection in 13 patients (17%), mechanical debridement with the rigid bronchoscope in 5 patients (7%), argon plasma coagulation in 4 (5%), contact electrocautery in 4 (5%), and cryotherapy in 1 patient (1%). Combined methods used were as follows: combined argon plasma and mechanical debridement in 42 patients (56%), combined laser and mechanical debridement in 3 patients (4%), argon plasma coagulation plus silicone stent insertion in 1 patient (1%), and laser plus nitinol stent in 1 patient (1%). Overall, 4 patients had moderate bleeding that was controlled endoscopically, and 1 patient had pneumothorax, which was treated with insertion of an intercostal drainage tube.
The median forced expiratory volume in 1 second (FEV1) before the therapeutic procedure was 1.7 L (1.0 to 3.0 L), and after the procedure it was 2.2 L (1.3 to 4.7 L; p < 0.0001). The median forced vital capacity (FVC) before the therapeutic bronchoscopy was 2.5 L (1.3 to 4.1 L), and after the procedure it was 3.3 L (1.96.1 L) (p < 0.0001). The median FEV1/FVC ratio before therapeutic bronchoscopy was 67%, and after the procedure it was 68% (p = 0.7; Fig 1). The changes in lung function before after endobronchial interventions in patients who subsequently underwent lobectomy, bilobectomy, or pneumonectomy are presented in Table 1.
|
|
| Comment |
|---|
|
|
|---|
In our study, lobectomy or bilobectomy was performed in 57% of patients (Table 2). Seventy-six percent of lesions were present in the main bronchi (Table 2). That would be an indication for pneumonectomy in many centers. In our study, a considerable number of patients could undergo sleeve resection. Parenchyma-sparing surgery in the form of lobectomy or bilobectomies were performed in 30 patients (41%) with lesions in the main bronchi (Table 2). The real impact of therapeutic interventions before lung resection surgery can be best confirmed by having a control group. There was no postoperative mortality or significant postoperative morbidity attributed to the interventional bronchoscopy procedure performed before the thoracotomy. The findings of our study lead us to believe that therapeutic bronchoscopy might permit lobectomies or bilobectomies and thereby has the potential to permit parenchyma-sparing surgery in patients with lung cancer.
|
It has been suggested that stent placement should be avoided in patients with potentially resectable malignant disease owing to the possible risks of mucous retention, infection, and damage to the healthy mucosa by stimulating granulation tissue formation [7]. In our study, stent insertion was undertaken in 2 patients, who later underwent a surgical procedure. In 1 patient, laser therapy was used, followed by Ultraflex stent insertion; and in another, argon plasma was used, followed by insertion of a Dumon stent. Combination therapy was chosen in these patients to ensure airway patency as both had severe post-stenotic pneumonia. These 2 patients subsequently underwent a pneumonectomy and a middle and lower bilobectomy, respectively.
According to the literature, in patients undergoing bronchoscopic palliation before surgery, the most common histologic diagnosis was squamous cell carcinoma (58%), and none had adenocarcinoma [7]. In our study, the most common histologic diagnosis was also squamous cell carcinoma (45%); however, adenocarcinoma was present in 19% of patients. That might be due to a changing pattern of presentation for adenocarcinoma, which is being increasingly observed in the central location [14]. The findings of our study show that patients with almost all varieties of non-small cell carcinoma of the lung can be treated with an interventional bronchoscopic procedure as a bridge to elective lung surgery.
Spirometry is one of the initial assessment parameters in the preoperative evaluation of patients undergoing lung surgery [15]. Improvement in lung function has been reported after bronchoscopic laser resection before surgical treatment [6, 7]. In a study of 24 patients, the median improvement in FEV1 and FVC after therapeutic bronchoscopy was 0.75 L and 0.6 L, respectively [7]. In our study, also, there was a significant improvement in both the FEV1 and FVC after therapeutic bronchoscopy. There was no change in the FEV1/FVC ratio before and after the therapeutic bronchoscopy, as there was an increase in both the FEV1 and FVC after the intervention. Therefore, the findings of improvement in spirometry values after therapeutic bronchoscopy before surgical resection are confirmed by our study in a much larger patient population.
In summary, most therapeutic bronchoscopy modalities currently available can be applied in the combined bronchoscopic and surgical management of patients with malignant airway obstruction. In this study, patients underwent a therapeutic interventional bronchoscopy procedure for malignant central airway obstruction followed by lung surgery, with a curative intent. Therapeutic bronchoscopy might permit parenchyma-sparing surgery in patients with lung cancer.
| Member and Individual Subscriber Access to the Online Annals |
|---|
|
|
|---|
Society members and non-members alike who do not know their CTSNet user name and password should follow the link "Forgot your user name or password?" that appears below the boxes where you are asked to enter this information when you try to gain full-text access. Your user name and password will be e-mailed to the e-mail address you designate.
In lieu of the above procedure, if you have forgotten your CTSNet username and/or password, you can always send an email to CTSNet via the feedback button from the left navigation menu on the homepage of the online Annals or go directly to http://ats.ctsnetjournals.org/cgi/feedback .
We hope that you will view the online Annals and take advantage of the many features available to our subscribers as part of the CTSNet Journals Online. These include inter-journal linking from within the reference sections of Annals' articles to over 350 journals available through the HighWire Press collection (HighWire provides the platform for the delivery of the online Annals). There is also cross-journal advanced searching, eTOC Alerts, Subject Alerts, Cite-Track, and much more. A listing of these features can be found at http://ats.ctsnetjournals.org/help/features.dtl
We encourage you to visit the online Annals at http://ats.ctsnetjournals.org and explore.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. A.P. Brokx, E. K. Risse, M. A. Paul, K. Grunberg, R. P. Golding, P. W.A. Kunst, J.-P. Eerenberg, J. C. van Mourik, P. E. Postmus, W. J. Mooi, et al. Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 973 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Chhajed, F. Baty, M. Pless, S. Somandin, M. Tamm, and M. H. Brutsche Outcome of Treated Advanced Non-small Cell Lung Cancer With and Without Central Airway Obstruction Chest, December 1, 2006; 130(6): 1803 - 1807. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |